Development of Ensemble Steric and Electrostatic Chirality (ESEC) descriptors for modelling chromatographic enantioseparations
Abstract
In this work, chiral molecular descriptors were defined using 2 distinct approaches: (1) scalar triple products of vectorial molecular properties, and (2) descriptors that attempt to quantify the amount of twist in the overall molecular shape. Because both approaches give rise to conformation dependence, descriptor values were averaged over a conformational ensemble obtained by Molecular Dynamics. In addition, a method is introduced that attempts to quantify the asymmetry of the distribution of the descriptor values over the conformational ensemble. The totality of the resulting descriptors were named "Ensemble Steric and Electrostatic Chirality (ESEC) descriptors". A pilot validation study was performed by building Quantitative Structure-Enantioselectivity Relationships (QSER), i.e. mathematical models to predict the chromatographic separation of enantiomers, using a test set of 43 structurally diverse pharmaceuticals analyzed on a polysaccharide-based chiral stationary phase. The best linear regression model (7 descriptors) for the chiral separation (expressed as selectivity factor) featured a low leave-one-out cross validation error (0.0814), a well-predicted elution sequence of the separated enantiomers (21 out of 23 molecules) and a well-predicted αRS for 27 out of 42 molecules. To the best of our knowledge, this is the first time that acceptable linear QSER models were obtained for chiral chromatographic separations of such a chemically diverse set of pharmaceuticals.
How strong is the evidence?
Evidence Hub reads this as a simulation / modelling, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.